Algo version: 0.98b
Smith & Nephew SNATS Inc. is listed at the NYSE Exchange
Smith & Nephew SNATS Inc. [SNN]
NYSE Sector: Healthcare Industry:Medical - Devices

Is Smith & Nephew SNATS Inc. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Smith & Nephew SNATS Inc. pays dividends. Last time was Friday 8th of November 2024 where the investors holding the stock on Friday 4th of October 2024 were paid $0.288 per share. Over the last 50 times between 2000 and 2024, Smith & Nephew SNATS Inc. has paid $18.5196 with an average of $0.37 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Smith & Nephew SNATS Inc. 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $47.57, you would have made a loss of $-16.09 per share or -33.82%

Yes, the average daily trading liquidity for Smith & Nephew SNATS Inc. is $754 130 thousand. You should therefore be able to get in and out of your positions relatively fast.

Smith & Nephew SNATS Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.21, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 4.75%, which is challenging.

We have calculated the inflation risk for Smith & Nephew SNATS Inc. to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.